News archive

Showing 699 results

September 2020

Statement Sep 30, 2020
Life Science Companies and the Bill & Melinda Gates Foundation: Joint Communique

Commitments to expanded global access for COVID-19 diagnostics, therapeutics, and vaccines.
Story Sep 23, 2020 Education and Awareness
Day of Reflection at Novartis

On this Day of Reflection, Novartis associates are thinking and talking about what it means to be part of a truly diverse and inclusive organization.
Media Release Sep 16, 2020
Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US
Media Release Sep 16, 2020
Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US

Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on social injustice Commitment to include…
Media Release Sep 11, 2020
Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis
Media Release Sep 11, 2020
Novartis presents data at ACTRIMS-ECTRIMS on the effects of treatment with Mayzent® (siponimod) studied on disability progression and cognitive processing speed in patients with progressing relapsing multiple sclerosis

Subgroup post hoc analysis of EXPAND reported that Mayzent reduced the risk of cognitive worsening and improved the chance of cognitive improvement at 6 months versus placebo in patients with…
Media Release Sep 11, 2020
Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis

New post hoc data from Phase III ASCLEPIOS trials showed newly diagnosed, treatment-naïve patients experienced reductions in annualized relapse rates and MRI lesion activity and prolonged time to…

August 2020

‹ Previous page
1
…
12
13
14
15
16
17
18
…
59
› Next page